ChemicalBook >> CAS DataBase List >>BDP 9066)

BDP 9066)

CAS No.
2226507-04-4
Chemical Name:
BDP 9066)
Synonyms
BDP 9066);rac-BDP9066;BDP9066 (BDP-9066;(6S)-8-[3-(4-Pyrimidinyl)-1H-pyrrolo[2,3-b]pyridin-4-yl]-1,8-diazaspiro[5.5]undecane;1,8-Diazaspiro[5.5]undecane, 8-[3-(4-pyrimidinyl)-1H-pyrrolo[2,3-b]pyridin-4-yl]-, (6S)-
CBNumber:
CB84844538
Molecular Formula:
C20H24N6
Molecular Weight:
348.44
MDL Number:
MFCD31807600
MOL File:
2226507-04-4.mol
Last updated:2024-07-02 08:55:37

BDP 9066) Properties

storage temp. Store at -20°C
solubility DMSO:10.0(Max Conc. mg/mL);28.7(Max Conc. mM)
form Solid
color Off-white to light brown

BDP 9066) price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
ChemScene CS-0040570 BDP9066 2226507-04-4 5mg $150 2021-12-16 Buy
ChemScene CS-0040570 BDP9066 2226507-04-4 10mg $250 2021-12-16 Buy
ChemScene CS-0040570 BDP9066 2226507-04-4 25mg $550 2021-12-16 Buy
ChemScene CS-0040570 BDP9066 2226507-04-4 50mg $950 2021-12-16 Buy
ChemScene CS-0040570 BDP9066 2226507-04-4 100mg $1650 2021-12-16 Buy
Product number Packaging Price Buy
CS-0040570 5mg $150 Buy
CS-0040570 10mg $250 Buy
CS-0040570 25mg $550 Buy
CS-0040570 50mg $950 Buy
CS-0040570 100mg $1650 Buy

BDP 9066) Chemical Properties,Uses,Production

Description

BDP9066 is a potent and selective MRCK inhibitor with an IC50 of 64 nM for MRCKβ in SCC12 cells, Ki values of 0.0136 nM . BDP9066 reduced substrate phosphorylation, leading to morphological changes in cancer cells along with inhibition of their motility and invasive character. In over 750 human cancer cell lines tested, BDP9066 displayed consistent anti-proliferative effects with greatest activity in hematological cancer cells. BDP-9066 prevented radiation-driven increases in motility both in vitro and in a clinically relevant orthotopic xenograft model of GBM. Crucially, treatment with BDP-9066 in combination with RT significantly increased survival in this model and markedly reduced infiltration of the contralateral cerebral hemisphere.

target

BDP9066 is a potent and selective myotonic dystrophy-related Cdc42-binding kinase MRCK inhibitor with an IC50 of 64 nM for MRCKβ in SCC12 cells, Ki values of 0.0136 nM and 0.0233 nM for MRCKα/β in house determinations, respectively.

BDP 9066) Preparation Products And Raw materials

Raw materials

Preparation Products

BDP 9066) Suppliers

Global( 9)Suppliers
Supplier Tel Email Country ProdList Advantage
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000 marketing@targetmol.com United States 19892 58
Shenyang Zhongshen Zekang Biomedical Technology Research Co., Ltd
+86-18341751992 +86-15382112998 757984502@qq.com China 892 58
Aladdin Scientific
+1-+1(833)-552-7181 sales@aladdinsci.com United States 52927 58
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627 info@efebio.com China 9806 58
Fan De(Beijing) Biotechnology Co., Ltd. 15911056312 liming@bio-fount.com China 9730 58
ShangHai ChuanQian Chemcial Technique Centre 15869524721 3525679403@qq.com China 3852 58
TargetMol Chemicals Inc. 4008200310 marketing@tsbiochem.com China 24647 58
Shenyang Zhongshen Zekang Biomedical Technology Research Co., Ltd 024-024-88590548 18341751992 757984502@qq.com China 891 58
BDP 9066) BDP9066 (BDP-9066 1,8-Diazaspiro[5.5]undecane, 8-[3-(4-pyrimidinyl)-1H-pyrrolo[2,3-b]pyridin-4-yl]-, (6S)- rac-BDP9066 (6S)-8-[3-(4-Pyrimidinyl)-1H-pyrrolo[2,3-b]pyridin-4-yl]-1,8-diazaspiro[5.5]undecane 2226507-04-4